These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12628493)

  • 1. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
    Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
    Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
    Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
    Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
    Katancik JA; Sharma A; de Nardin E
    Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrete steps in binding and signaling of interleukin-8 with its receptor.
    Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
    J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo.
    Lee JS; Frevert CW; Wurfel MM; Peiper SC; Wong VA; Ballman KK; Ruzinski JT; Rhim JS; Martin TR; Goodman RB
    J Immunol; 2003 May; 170(10):5244-51. PubMed ID: 12734373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
    Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
    Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface heparan sulfate participates in CXCL1-induced signaling.
    Wang D; Sai J; Richmond A
    Biochemistry; 2003 Feb; 42(4):1071-7. PubMed ID: 12549928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.
    Lippert U; Artuc M; Grützkau A; Möller A; Kenderessy-Szabo A; Schadendorf D; Norgauer J; Hartmann K; Schweitzer-Stenner R; Zuberbier T; Henz BM; Krüger-Krasagakes S
    J Immunol; 1998 Sep; 161(5):2600-8. PubMed ID: 9725262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
    Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
    Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.
    Van den Steen PE; Proost P; Wuyts A; Van Damme J; Opdenakker G
    Blood; 2000 Oct; 96(8):2673-81. PubMed ID: 11023497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis.
    Yang W; Schraw WP; Mueller SG; Richmond A
    Biochemistry; 1997 Dec; 36(49):15193-200. PubMed ID: 9398246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB.
    Nilsson G; Mikovits JA; Metcalfe DD; Taub DD
    Blood; 1999 May; 93(9):2791-7. PubMed ID: 10216072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
    Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
    Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.
    Ahuja SK; Lee JC; Murphy PM
    J Biol Chem; 1996 Jan; 271(1):225-32. PubMed ID: 8550564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR2 stimulation primes CXCR1 [Ca2+]i responses to IL-8 in human neutrophils.
    Hauser CJ; Fekete Z; Goodman ER; Kleinstein E; Livingston DH; Deitch EA
    Shock; 1999 Dec; 12(6):428-37. PubMed ID: 10588510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists.
    Navarro J
    Biochemistry; 2019 Mar; 58(10):1432-1439. PubMed ID: 30726064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8.
    Fan X; Patera AC; Pong-Kennedy A; Deno G; Gonsiorek W; Manfra DJ; Vassileva G; Zeng M; Jackson C; Sullivan L; Sharif-Rodriguez W; Opdenakker G; Van Damme J; Hedrick JA; Lundell D; Lira SA; Hipkin RW
    J Biol Chem; 2007 Apr; 282(16):11658-66. PubMed ID: 17197447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
    Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB
    J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of involvement of CXC-chemokines in proliferation of cultivated human melanocytes.
    Mockenhaupt M; Peters F; Schwenk-Davoine I; Herouy Y; Schraufstätter I; Elsner P; Norgauer J
    Int J Mol Med; 2003 Oct; 12(4):597-601. PubMed ID: 12964041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation.
    Merz D; Liu R; Johnson K; Terkeltaub R
    J Immunol; 2003 Oct; 171(8):4406-15. PubMed ID: 14530367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.